Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 2/20 | 0.59 |
| ▸ | FAAH | O00519 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.50 |
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.49 |
| ▸ | CES2 | O00748 | 1/20 | 0.48 |
| ▸ | CES1 | P23141 | 1/20 | 0.48 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL800064 | 0.98 | EPHX2 (0.56) | EPHX2FAAHALDH1A1HPGDUSP2 | |
| SCHEMBL4656202 | 0.94 | ALDH1A1 (0.56) | EPHX2FAAHALDH1A1HPGDUSP2 | |
| SCHEMBL1155730 | 0.90 | FAAH (0.55) | EPHX2FAAHALDH1A1HPGDUSP2 | |
| SCHEMBL6840220 | 0.84 | SRD5A2 (0.56) | EPHX2ALDH1A1MEN1KMT2ANPSR1 | |
| SCHEMBL24117533 | 0.81 | CYP19A1 (0.59) | ALDH1A1CYP2C19KDM4EMEN1KMT2A | |
| SCHEMBL1477277 | 0.81 | GBA1 (0.50) | EPHX2FAAHALDH1A1HPGDCES2 | |
| SCHEMBL4674087 | 0.81 | FAAH (0.47) | EPHX2FAAHALDH1A1HPGDUSP2 | |
| SCHEMBL2585173 | 0.81 | NPC1 (0.42) | EPHX2ALDH1A1L3MBTL1 | |
| SCHEMBL11586847 | 0.81 | EPHX2 (0.56) | EPHX2ALDH1A1HPGDUSP2CYP2C19 | |
| SCHEMBL11880887 | 0.81 | ALDH1A1 (0.63) | EPHX2ALDH1A1HPGDUSP2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8697199-B2 | Calamitic mesogenic compounds | MERCK PATENT GMBH (DE) | 2014-04-15 | — | — | US | claimed |
| US-8323527-B2 | Fluorene derivatives | MERCK PATENT GMBH (DE) | 2012-12-04 | — | — | US | claimed |
| EP-2183336-B1 | CALAMITIC MESOGENIC COMPOUNDS | MERCK PATENT GMBH (DE) | 2011-11-02 | — | — | EP | claimed |
| EP-2183337-B1 | FLUORENE DERIVATIVES | MERCK PATENT GMBH (DE) | 2011-07-20 | — | — | EP | claimed |
| US-20100301271-A1 | FLUORENE DERIVATIVES | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2010-12-02 | — | — | US | claimed |
| US-20100201920-A1 | Calamitic Mesogenic Compounds | MERCK PATENT GESELLSCHAFT (DE) | 2010-08-12 | — | — | US | claimed |
| US-20100179343-A1 | METHOD OF PRODUCING AN OPTICALLY ACTIVE CYANOHYDRIN DERIVATIVE | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2010-07-15 | — | — | US | claimed |
| EP-2183337-A1 | FLUORENE DERIVATIVES | Merck Patent GmbH (DE) | 2010-05-12 | — | — | EP | claimed |
| EP-2183336-A1 | CALAMITIC MESOGENIC COMPOUNDS | Merck Patent GmbH (DE) | 2010-05-12 | — | — | EP | claimed |
| CN-101663256-A | Process for producing optically active cyanohydrin derivative | AGENCY SCIENCE TECH & RES | 2010-03-03 | — | — | CN | claimed |
| WO-2009030332-A1 | CALAMITIC MESOGENIC COMPOUNDS | MERCK PATENT GMBH (DE) | 2009-03-12 | — | — | WO | claimed |
| WO-2008121074-A1 | METHOD OF PRODUCING AN OPTICALLY ACTIVE CYANOHYDRIN DERIVATIVE | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2008-10-09 | — | — | WO | claimed |
| EP-1773331-A1 | IMIDAZOLE AND THIAZOLE DERIVATIVES AS ANTIVIRAL AGENTS | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) | 2007-04-18 | — | — | EP | claimed |
| WO-2006008556-A1 | IMIDAZOLE AND THIAZOLE DERIVATIVES AS ANTIVIRAL AGENTS | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) | 2006-01-26 | — | — | WO | claimed |
| US-6388081-B1 | 4-substituted-quinoline derivatives and 4-substituted-quinoline combinatorial libraries | LION BIOSCIENCE AG (DE) | 2002-05-14 | — | — | US | claimed |
| US-6262269-B1 | 4-Substituted-quinoline derivatives and 4-substituted-quinoline combinatorial libraries | TREGA BIOSCIENCES, INC. | 2001-07-17 | — | — | US | claimed |
| EP-0983507-A1 | TRICYCLIC TETRAHYDROQUINOLINE DERIVATIVES AND TRICYCLIC TETRAHYDROQUINOLINE COMBINATORIAL LIBRARIES | Trega Biosciences, Inc. (US) | 2000-03-08 | — | — | EP | claimed |
| EP-0977989-A1 | 4-SUBSTITUTED-QUINOLINE DERIVATIVES AND 4-SUBSTITUTE-QUINOLINE COMBINATORIAL LIBRARIES | TREGA BIOSCIENCES, INC. (US) | 2000-02-09 | — | — | EP | claimed |
| WO-1998034115-A1 | 4-SUBSTITUTED-QUINOLINE DERIVATIVES AND 4-SUBSTITUTE-QUINOLINE COMBINATORIAL LIBRARIES | TREGA BIOSCIENCES, INC. (US) | 1998-08-06 | — | — | WO | claimed |
| WO-1998034111-A1 | TRICYCLIC TETRAHYDROQUINOLINE DERIVATIVES AND TRICYCLIC TETRAHYDROQUINOLINE COMBINATORIAL LIBRARIES | TREGA BIOSCIENCES, INC. (US) | 1998-08-06 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100179343-A1 | METHOD OF PRODUCING AN OPTICALLY ACTIVE CYANOHYDRIN DERIVATIVE | TDO2, AOX1, DAO | EPHX2 438/4885FAAH 2360/4885ALDH1A1 472/4885 |
| US-20100301271-A1 | FLUORENE DERIVATIVES | FLNA, FLNB, AFF2 | EPHX2 2324/4885FAAH 925/4885ALDH1A1 3616/4885 |
| US-20100201920-A1 | Calamitic Mesogenic Compounds | CALD1, CALR, CALU | EPHX2 3885/4885FAAH 2535/4885ALDH1A1 4510/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.